Kymera Therapeutics Statistics
Total Valuation
KYMR has a market cap or net worth of $10.94 billion. The enterprise value is $9.37 billion.
| Market Cap | 10.94B |
| Enterprise Value | 9.37B |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KYMR has 85.37 million shares outstanding. The number of shares has increased by 17.58% in one year.
| Current Share Class | 85.37M |
| Shares Outstanding | 85.37M |
| Shares Change (YoY) | +17.58% |
| Shares Change (QoQ) | +1.96% |
| Owned by Insiders (%) | 1.15% |
| Owned by Institutions (%) | 90.91% |
| Float | 68.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 106.99 |
| Forward PS | 347.49 |
| PB Ratio | 6.77 |
| P/TBV Ratio | 6.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 91.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.13, with a Debt / Equity ratio of 0.05.
| Current Ratio | 11.13 |
| Quick Ratio | 10.82 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,340.70 |
Financial Efficiency
Return on equity (ROE) is -27.29% and return on invested capital (ROIC) is -18.60%.
| Return on Equity (ROE) | -27.29% |
| Return on Assets (ROA) | -17.64% |
| Return on Invested Capital (ROIC) | -18.60% |
| Return on Capital Employed (ROCE) | -24.14% |
| Weighted Average Cost of Capital (WACC) | 15.31% |
| Revenue Per Employee | $374,487 |
| Profits Per Employee | -$1.28M |
| Employee Count | 273 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +113.85% in the last 52 weeks. The beta is 2.03, so KYMR's price volatility has been higher than the market average.
| Beta (5Y) | 2.03 |
| 52-Week Price Change | +113.85% |
| 50-Day Moving Average | 115.44 |
| 200-Day Moving Average | 97.62 |
| Relative Strength Index (RSI) | 62.25 |
| Average Volume (20 Days) | 984,763 |
Short Selling Information
The latest short interest is 9.17 million, so 10.74% of the outstanding shares have been sold short.
| Short Interest | 9.17M |
| Short Previous Month | 9.91M |
| Short % of Shares Out | 10.74% |
| Short % of Float | 13.44% |
| Short Ratio (days to cover) | 10.32 |
Income Statement
In the last 12 months, KYMR had revenue of $102.24 million and -$349.43 million in losses. Loss per share was -$3.62.
| Revenue | 102.24M |
| Gross Profit | -327.75M |
| Operating Income | -404.89M |
| Pretax Income | -349.43M |
| Net Income | -349.43M |
| EBITDA | -398.38M |
| EBIT | -404.89M |
| Loss Per Share | -$3.62 |
Balance Sheet
The company has $971.21 million in cash and $76.60 million in debt, with a net cash position of $1.57 billion or $18.38 per share.
| Cash & Cash Equivalents | 971.21M |
| Total Debt | 76.60M |
| Net Cash | 1.57B |
| Net Cash Per Share | $18.38 |
| Equity (Book Value) | 1.61B |
| Book Value Per Share | 18.92 |
| Working Capital | 908.87M |
Cash Flow
In the last 12 months, operating cash flow was -$287.57 million and capital expenditures -$1.33 million, giving a free cash flow of -$288.89 million.
| Operating Cash Flow | -287.57M |
| Capital Expenditures | -1.33M |
| Depreciation & Amortization | 6.51M |
| Net Borrowing | -1.72M |
| Free Cash Flow | -288.89M |
| FCF Per Share | -$3.38 |
Margins
| Gross Margin | n/a |
| Operating Margin | -396.04% |
| Pretax Margin | -341.79% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KYMR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.58% |
| Shareholder Yield | -17.58% |
| Earnings Yield | -2.83% |
| FCF Yield | -2.64% |
Analyst Forecast
The average price target for KYMR is $144.57, which is 12.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $144.57 |
| Price Target Difference | 12.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | 0.30% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KYMR has an Altman Z-Score of 26.32 and a Piotroski F-Score of 4.
| Altman Z-Score | 26.32 |
| Piotroski F-Score | 4 |